Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Filings indexed 508 across all filing types
Latest filing 2020-03-12 Proxy Solicitation & In…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 98% confidence The document is a 'Reference Document' (참고서류) for a General Meeting of Shareholders (제24기 정기주주총회) for the company Helixmith (헬릭스미스). It includes details on the meeting date, location, agenda items, and proxy solicitation information (위임권유). It also contains financial statements (재무제표) as part of the management's reporting for the meeting. This type of document is standard for proxy solicitation and shareholder meeting materials, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-12 Korean
불성실공시법인지정(공시불이행)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory notice regarding the designation of the company as an 'unfaithful disclosure corporation' (불성실공시법인) due to a delay in reporting. It details the regulatory violation, the penalty (fine), and the legal basis under KOSDAQ market disclosure regulations. Since this is a specific regulatory announcement regarding compliance and penalties that does not fit into financial reporting or corporate action categories, it is classified as a Regulatory Filing (RNS).
2020-03-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by BlackRock Fund Advisors regarding their stake in Helixmith. This type of filing is a standard regulatory requirement in South Korea (under the Capital Markets Act) when an entity crosses a 5% ownership threshold. It details the reporting entity, special relationships, and the purpose of the holding (simple investment). This falls under the 'Major Shareholding Notification' category.
2020-03-05 Korean
기타경영사항(특허권취득)(자율공시)(항-c-Met 항체 및 이의 용도 일본 특허 취득)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (항-c-Met 항체 및 이의 용도) by Helixmith. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a regulatory disclosure of a corporate event that does not fall into the other specialized categories, it is classified as a general regulatory filing.
2020-02-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties (insiders). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-02-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details specific share transactions (purchases) made by an executive (CFO Hannik Na) of Helixmith. This falls under the category of Director's Dealing, which covers insider trades and share transactions by company directors and executives.
2020-02-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.